- Home
- ELVA vs THTX Comparison
ELVA vs THTX Comparison
Compare ELVA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- THTX
- Stock Information
- Founded
- ELVA 1996
- THTX 1993
- Country
- ELVA Canada
- THTX Canada
- Employees
- ELVA N/A
- THTX N/A
- Industry
- ELVA
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ELVA
- THTX Health Care
- Exchange
- ELVA Nasdaq
- THTX Nasdaq
- Market Cap
- ELVA 125.5M
- THTX 119.1M
- IPO Year
- ELVA N/A
- THTX N/A
- Fundamental
- Price
- ELVA $3.30
- THTX $2.36
- Analyst Decision
- ELVA Strong Buy
- THTX Hold
- Analyst Count
- ELVA 5
- THTX 1
- Target Price
- ELVA $6.10
- THTX N/A
- AVG Volume (30 Days)
- ELVA 87.3K
- THTX 131.7K
- Earning Date
- ELVA 08-12-2025
- THTX 07-09-2025
- Dividend Yield
- ELVA N/A
- THTX N/A
- EPS Growth
- ELVA N/A
- THTX N/A
- EPS
- ELVA N/A
- THTX N/A
- Revenue
- ELVA $48,016,000.00
- THTX $88,666,000.00
- Revenue This Year
- ELVA $55.29
- THTX N/A
- Revenue Next Year
- ELVA $63.69
- THTX $15.13
- P/E Ratio
- ELVA N/A
- THTX N/A
- Revenue Growth
- ELVA N/A
- THTX 13.52
- 52 Week Low
- ELVA $1.67
- THTX $1.12
- 52 Week High
- ELVA $3.71
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- ELVA 50.37
- THTX 40.11
- Support Level
- ELVA $3.17
- THTX $2.24
- Resistance Level
- ELVA $3.53
- THTX $2.62
- Average True Range (ATR)
- ELVA 0.16
- THTX 0.10
- MACD
- ELVA -0.03
- THTX -0.02
- Stochastic Oscillator
- ELVA 28.26
- THTX 31.58
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.